Wolverine Trading, LLC Immunity Bio, Inc. Put Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
BUY
$3.23 - $6.17 $143,735 - $274,565
44,500 Added 304.79%
59,100 $317,000
Q4 2023

Feb 14, 2024
BUY
$1.25 - $5.21 $2,500 - $10,420
2,000 Added 15.87%
14,600 $73,000
Q3 2023

Nov 15, 2023
SELL
$1.29 - $3.1 $20,898 - $50,220
-16,200 Reduced 56.25%
12,600 $21,000
Q2 2023

Aug 23, 2023
BUY
$1.53 - $6.41 $11,169 - $46,793
7,300 Added 33.95%
28,800 $80,000
Q1 2023

May 15, 2023
SELL
$1.35 - $4.78 $16,470 - $58,316
-12,200 Reduced 36.2%
21,500 $38,000
Q4 2022

Feb 14, 2023
BUY
$4.35 - $6.77 $87,870 - $136,754
20,200 Added 149.63%
33,700 $171,000
Q3 2022

Nov 14, 2022
BUY
$3.65 - $6.43 $10,220 - $18,004
2,800 Added 26.17%
13,500 $67,000
Q2 2022

Aug 15, 2022
SELL
$2.68 - $6.14 $68,876 - $157,798
-25,700 Reduced 70.6%
10,700 $40,000
Q1 2022

May 16, 2022
BUY
$5.05 - $7.53 $47,975 - $71,535
9,500 Added 35.32%
36,400 $214,000
Q4 2021

Feb 14, 2022
BUY
$5.67 - $10.18 $152,523 - $273,842
26,900 New
26,900 $172,000
Q3 2021

Nov 12, 2021
SELL
$9.17 - $14.24 $187,985 - $291,920
-20,500 Closed
0 $0
Q2 2021

Aug 06, 2021
SELL
$13.41 - $22.4 $332,568 - $555,520
-24,800 Reduced 54.75%
20,500 $298,000
Q1 2021

May 14, 2021
BUY
$12.83 - $42.25 $581,199 - $1.91 Million
45,300 New
45,300 $1.08 Million

Others Institutions Holding IBRX

# of Institutions
204
Shares Held
70M
Call Options Held
1.68M
Put Options Held
1.31M
View Full List

About ImmunityBio, Inc.

IBRX Quotes by TradingView
  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.05B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email